Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Guidance on cannabis-based products

NHS England has issued guidance on the use of cannabis-based products for medicinal use.

Following high-profile news stories over the summer, the Home Office reviewed the legal status of cannabis-based products for medicinal use. In light of evidence of therapeutic benefit in certain medical conditions these products will be rescheduled.

The guidance document notes that cannabis-based products for medicinal use should only be prescribed:

  • for indications where there is clear published evidence of benefit or UK
    Guidelines
  • where there is a clinical need which cannot be met by a licensed medicine
  • where established treatment options have been exhausted
  • under the prescription or direction of a specialist doctor (listed on the Specialist Register of the General Medical Council)

Action: Clinicians should be aware of this guidance. It essentially rules out prescribing in primary care and places restrictions on specialist prescribing.

Share 'Guidance on cannabis-based products' on Email Share 'Guidance on cannabis-based products' on Delicious Share 'Guidance on cannabis-based products' on Digg Share 'Guidance on cannabis-based products' on Facebook Share 'Guidance on cannabis-based products' on reddit Share 'Guidance on cannabis-based products' on StumbleUpon Share 'Guidance on cannabis-based products' on Twitter

atomic-wealth

No Comments to “Guidance on cannabis-based products”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer